-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

637.O1.6 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Treatment and Prognostication of MDS

Symposia: Myelodysplastic Syndromes: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
MDS, Acute Myeloid Malignancies, AML, Research, Clinical trials, Adult, Drug development, Translational Research, MPN, Clinical Research, Genomics, Health outcomes research, Chronic Myeloid Malignancies, CMML, Diseases, Treatment Considerations, Real-world evidence, Myeloid Malignancies, Biological Processes, Human, Study Population
Sunday, December 8, 2024: 4:30 PM-6:00 PM
Harbor Ballroom DEFG (Manchester Grand Hyatt San Diego)
Moderators:
David Sallman, MD, H. Lee Moffitt Cancer Center and Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre
Disclosures:
Chee: Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees; Otsuka: Honoraria, Membership on an entity's Board of Directors or advisory committees; Keros Therapeutics: Consultancy, Honoraria.
4:30 PM

Samuel Urrutia, MD1, Koji Sasaki, MD2, Alex Bataller, MD, PhD2*, Hagop M. Kantarjian, MD3, Guillermo Montalban-Bravo, MD2, James McCloskey, MD4, Elizabeth A. Griffiths, MD5, Karen Yee, MD, FRCPC6*, Amer M. Zeidan, MBBS, MHS7, Michael R. Savona, MD8, Aram Oganesian, PhD9*, Yuri Sano, MD, PhD10, Harold N. Keer, MD, PhD10 and Guillermo Garcia-Manero, MD2

1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3University of Texas MD Anderson Cancer Center, Houston, TX
4John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
5Roswell Park Comprehensive Cancer Center, Buffalo, NY
6Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
7Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
8Vanderbilt University Medical Center, Nashville, TN
9OTSUKA AMERICA PHARMACEUTICALS, INC., Princeton, NJ
10Astex Pharmaceuticals, Inc., Pleasanton, CA

4:45 PM

Guillermo Garcia-Manero, MD1, James McCloskey, MD2, Bart L. Scott, MD3, Elizabeth A. Griffiths, MD4, Bonnie Kiner-Strachan, MD5, Andrew M. Brunner, MD6, Amer M. Zeidan, MBBS, MHS7, Elie Traer, MD, PhD8, Yazan F. Madanat, MD9, Janelle Meyer, MD10*, Harry Erba, MD, PhD11*, Praneeth Baratam, MBBS12, Uma Borate, MD13, Yuri Sano, MD, PhD14, Aram Oganesian, PhD, DABT14*, Lixia Zhu15*, Harold N. Keer, MD, PhD14 and Michael R. Savona, MD16*

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
3Fred Hutchinson Cancer Center, Seattle, WA
4Roswell Park Comprehensive Cancer Center, Buffalo, NY
5New York University Langone Hospital Long Island, Mineola, NY
6Dana-Farber Cancer Institute, Boston, MA
7Smillow Cancer Hospital, New Haven, CT
8Knight Cancer Institute, Oregon Health & Science University, Portland, OR
9Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
10Oregon Oncology Specialists, Salem, OR
11Duke Cancer Institute, Durham, NC
12Hollings Cancer Center, Charleston, SC
13The Ohio State University, Columbus, OH
14Taiho Oncology, Inc., Princeton, NJ
15Taiho Oncology, Inc.., Princeton, NJ
16Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN

5:00 PM

Hongyan Tong, PhD1,2,3,4, Xinping Zhou1,2,3,5*, Yanjuan Lin6*, Yan Gao7*, Zheng Ge, MD, PhD8, Huang Li9*, Jin Zhang10*, Hai Cheng11*, Guifang Ouyang12*, Fanjun Meng13*, Yulu Tian14*, Yuemin Kuang15*, Fengping Zhou16*, Lixia Sheng12*, Weimei Jin5*, Gaixiang Xu1,2,3,4*, Liya Ma1,2,3,4*, Li Ye1,2,3,17*, Chen Mei5*, Jian Li18* and Jie Jin, M.D.2,19,20,21

1Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China
2Zhejiang University Cancer Center, Hangzhou, China
3Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China
4Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
7Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, CHN
8Jiangsu Provincial People’s Hospital, Nanjing, China
9Department of Hematology, The Affiliated Jinhua Hospital of Wenzhou Medical University, Wenzhou, China
10Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
11Department of Hematology, The Affiliated Hospotal of Xuzhou Medical College, Xuzhou, China
12Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China
13Department of Hematology, The Affiliated Hospital of Qingdao University,, Qiangdao, China
14Department of Hematology, Zhongda Hospital, Institute of Hematology Southeast University, School of Medicine, Southeast University,, Nanjing, China
15Department of Hematology, The Affiliated Jinhua Hospital of Wenzhou Medical University, Jinhua, China
16Department of Hematology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
17Department of Hematology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
18Clinical Research Center, Ruijin Hospital Affiliated To Shanghai Jiao Tong Unive, Shanghai, China
19Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
20Zhejiang Provincial Clinical Research Center For Hematological disorders, Hangzhou, China
21Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China

5:15 PM

Benjamin Rolles, MD1,2, Jan Philipp Bewersdorf, MD3,4, Tariq Kewan, MD5, Ondrej Blaha, PhD6*, Jessica M. Stempel, MD3, Luca Lanino, MD7, Najla H. Al Ali, Ms8*, Amy E. DeZern, MD, MHS9, Mikkael A. Sekeres, MD10, Geoffrey L. Uy, MD11, Hetty E. Carraway, MD, MBA12, Pinkal Desai13, Elizabeth A. Griffiths, MD14, Eytan M. Stein, MD15, Andrew M. Brunner, MD16, Christine M. McMahon, MD17, Rory M. Shallis, MD3, Joshua F. Zeidner, MD18, Michael R. Savona, MD19, Stacey M. Frumm, MD20, Shougat Barua21*, Namrata S. Chandhok, MD10, Constantine Logothetis, MD11, Aram Bidikian, MD3, Ted M. Getz, MD3, Gail J. Roboz, MD22, Eunice S. Wang, MD23, Amyah C. Harris16*, Maria L Amaya, MD, PhD17, Hayley Hawkins24*, Somedeb Ball, MD19, Justin Grenet, MD, MPhil13, Zhuoer Xie, MD, MS25, Yazan F Madanat, MD26, Yasmin Abaza, MD27, Talha Badar, MD28, Torsten Haferlach, MD29, Jaroslaw Maciejewski30, David Sallman, MD31, Anoop K Enjeti, MBBS, FRCPA, MD, MRCP32, Kamal Al-Rabi, MD33*, Khalid Halahleh, MD33*, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA34, Maria Diez-Campelo, MD, PhD35*, David Valcarcel, MD, PhD36, Claudia Haferlach, MD29, Lisa Pleyer, MD37*, Ioannis Kotsianidis, PhD38, Vassiliki Pappa, MD39, Valeria Santini, MD40, Angela Consagra, MD40*, Aref Al-Kali, MD41, Seishi Ogawa, MD, PhD42, Yasuhito Nannya, MD, PhD42, Matteo Giovanni Della Porta, MD43*, Rami S. Komrokji, MD25, Amer M. Zeidan, MBBS, MHS3 and Maximilian Stahl, MD2

1Division of Hematology, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Department of Internal Medicine, Section of Hematology, Yale University, New Haven
4Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
5Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
6School of Public Health, Yale Center for Analytical Sciences, Yale University, New Haven
7IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
8Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa
9Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore
10Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami
11Washington University School of Medicine, Saint Louis
12Department of Hematology and Medical Oncology, Taussig Cancer Institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
13Weill Cornell Medicine, New York City
14Roswell Park Comprehensive Cancer Center, Buffalo, NY
15Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York City
16Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston
17University of Colorado, Aurora
18Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill
19Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville
20Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston
21Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
22Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY
23Roswell Park Comprehensive Cancer Center, Buffalo
24Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
25Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, FL
26Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas
27Northwestern University, Chicago
28Division of Hematology-Oncology, Mayo Clinic, Jacksonville
29MLL Munich Leukemia Laboratory, Munich, Germany
30Department of Hematology and Medical Oncology, Taussig Cancer Institute, Leukemia Program, Cleveland Clinic, Cleveland
31Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa
32Department of Haematology, Calvary Mater Hospital, Newcastle, Australia
33King Hussein Cancer Center, Amman, Jordan
34Department of Haematology, The Royal Adelaide Hospital, Adelaide, SA, Australia
35Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain
36Department of Hematology and Oncology, University Hospital Vall d'Hebron, Barcelona, Spain
373rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria
38Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece
39Hematology Division, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece
40MDS Unit, Hematology, AOU Careggi ‐ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
41Mayo Clinic, Rochester
42Department of Pathology and Tumor Biology, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan
43IRCCS Humanitas Clinical and Research Center, Rozzano, Italy

5:30 PM

Elena Riva, PhD1*, Michela Calvi, PhD2,3*, Matteo Zampini, PhD1,4*, Lorenzo Dall'Olio, PhD5*, Alessandra Merlotti, PhD6,7*, Antonio Russo, MD3*, Giulia Maggioni, MD3*, Lara Orlandi2,3*, Alessandro Frigo3*, Francesca Ficara, PhD3,8*, Laura Crisafulli, PhD1,8*, Elisabetta Sauta, PhD3*, Saverio D'Amico, MSc3*, Enrico Lugli, PhD3*, Alessia Campagna, MD3*, Marta Ubezio, MD3*, Cristina Astrid Tentori, MD3*, Gabriele Todisco, MD3,9*, Luca Lanino, MD1, Alessandro Buizza, MD3*, Denise Ventura, MSc1*, Nicole Pinocchio, MSc1*, Elena Saba, PhD1*, Armando Santoro, MD10*, Valeria Santini, MD11, Arjan A. van de Loosdrecht, MD, PhD12*, Rami S. Komrokji, MD13, Guillermo Garcia-Manero, MD14, Pierre Fenaux, MD15, Lionel Ades, MD, PhD16, Uwe Platzbecker, MD17, Torsten Haferlach, MD18, Antonio Medina Almeida, MD, PhD19, Amer M. Zeidan, MBBS, MHS20, Shahram Kordasti, MD, PhD21,22, Daniel Remondini, PhD6*, Gastone Castellani, PhD23*, Clara Di Vito, PhD2,3*, Domenico Mavilio, MD, PhD2,3* and Matteo Giovanni Della Porta, MD3,4*

1IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
2Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy
3IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
4Department of Biomedical Sciences, Humanitas University, Milan, Italy
5Data Science and Bioinformatics Laboratory, IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy
6Department of Physics and Astronomy, DIFA, University of Bologna, Bologna, Italy
7IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
8Institute for Genetic and Biomedical Research, Milan Unit, CNR, Milan, Italy
9Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
10IRCCS Humanitas Research Hospital, Rozzano, Italy
11MDS Unit, Hematology, AOUC, University of Florence, Florence, Italy
12Department of Hematology, Amsterdam University Medical Center, Free University, Amsterdam, Netherlands
13Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
14Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
15Hopital Saint Louis, Groupe Francophone des Myelodysplasies, Paris, France, PARIS, FRA
16Hopital Saint Louis, Paris, France
17Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
18MLL Munich Leukemia Laboratory, Munich, Germany
19Hospital Da Luz Lisboa, Lisbon, Portugal
20Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
21Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
22Hematology Unit, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy
23Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy

5:45 PM

Maria Julia Montoro, MD, PhD1*, Laura Palomo, PhD1*, Claudia Haferlach, MD2, Pamela Acha3*, Onyee Chan, MD4*, Víctor Navarro5*, Yasuo Kubota, MD, PhD6*, Felicitas Schulz7*, Robert Briski8*, Najla H Al Ali, MS9*, Blanca Xicoy10*, Felix Lopez, MD11*, Francesc Bosch, MD, PhD1, Manja Meggendorfer, PhD12, Teresa González, PhD13*, Lea Naomi Eder14*, Andres Jerez, MD, PhD15*, Yu-Hung Wang, MD16*, Alessia Campagna, MD17*, Valeria Santini, MD18, Teresa Bernal19*, Esperanza Such, PhD20*, Hwei-Fang Tien, MD, PhD21, Anne Sophie Kubasch, MD22, Nicolas Díaz Varela, MD19*, Uwe Platzbecker, MD23, Detlef Haase, Prof. Dr. med.24*, Maria Diez-Campelo, MD, PhD13*, Matteo Giovanni Della Porta, MD17*, Guillermo Garcia-Manero, MD25, Daniel H Wiseman, MB ChB PhD MRCP FRCPath26*, Ulrich Germing, MD27*, Jaroslaw Maciejewski6, Rami S. Komrokji, MD9, Francesc Sole, PhD28, Torsten Haferlach, MD2 and David Valcarcel, MD, PhD29

1Department of Hematology, Vall d’Hebron University Hospital, Barcelona, Spain
2MLL Munich Leukemia Laboratory, Munich, Germany
3Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain
4H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Oncology Data Science (ODysSey), Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d’Hebron, Barcelona, Spain
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Department of Hematology, University Hospital of Düsseldorf, Düsseldorf, Germany
8University of Michigan, Grosse Pointe Woods, MI
9Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
10Myelodysplastic Syndromes Research Group, Josep Carreras Laeukemia Research Institute, Badalona, Spain
11Department of Hematology, Hospital del Mar, Barcelona, Spain
12MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
13University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Department of Hematology - Hospital Universitario de Salamanca, Salamanca, Spain
14Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Georg-August- University, Göttingen, Germany
15Hospital Morales Meseguer, Murcia, Murcia, ESP
16Department of Internal Medicine, Fra-Eastern Memorial Hospital, Taipei, Taiwan
17IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
18MDS Unit, Hematology, AOUC, University of Florence, Florence, Italy
19Hospital Universitario Central de Asturias, Instituto Universitario (IUOPA), Instituto de Investigación del Principado de Asturias (ISPA), Oviedo, Spain
20Hematology Research Group, Hospital Universitari I PolitèCnic La Fe; Dep. of Hematology, University, Valencia, Spain
21Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei, Taiwan
22Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
23Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
24Clinics of Hematology and Medical Oncology, INDIGHO laboratory, University Medical Center Göttingen (UMG), Göttingen, Germany
25Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
26The Christie NHS Foundation Trust, Manchester, United Kingdom
27Department of Hematology, Oncology and Clinical Immunology, University Medical Center Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany
28Josep Carreras Leukaemia Research Institute, Myelodysplastic Syndromes Research Group, Badalona, Spain
29Department of Hematology, Vall d’Hebron Institute of Oncology, University Hospital Vall d’Hebron,, Barcelona, Spain

*signifies non-member of ASH